The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)

Abstract Introduction This article examines the potential of using liquid biopsy with piRNAs to study cancer survival outcomes. While previous studies have explored the relationship between piRNA expression and cancer patient outcomes, a comprehensive investigation is still lacking. To address this...

Full description

Bibliographic Details
Main Authors: Mohammad Taghizadeh, Tohid Jafari-Koshki, Vahid Jafarlou, Mortaza Raeisi, Leila Alizadeh, Yousef Roosta, Somaieh Matin, Rahele Jabari, Daniel Sur, Abbas Karimi
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-12180-2
_version_ 1797199395097149440
author Mohammad Taghizadeh
Tohid Jafari-Koshki
Vahid Jafarlou
Mortaza Raeisi
Leila Alizadeh
Yousef Roosta
Somaieh Matin
Rahele Jabari
Daniel Sur
Abbas Karimi
author_facet Mohammad Taghizadeh
Tohid Jafari-Koshki
Vahid Jafarlou
Mortaza Raeisi
Leila Alizadeh
Yousef Roosta
Somaieh Matin
Rahele Jabari
Daniel Sur
Abbas Karimi
author_sort Mohammad Taghizadeh
collection DOAJ
description Abstract Introduction This article examines the potential of using liquid biopsy with piRNAs to study cancer survival outcomes. While previous studies have explored the relationship between piRNA expression and cancer patient outcomes, a comprehensive investigation is still lacking. To address this gap, we conducted a systematic review and meta-analysis of existing literature. Methods We searched major online databases up to February 2024 to identify articles reporting on the role of piRNA in cancer patient survival outcomes. Our meta-analysis used a random-effects model to pool hazard ratios with 95% confidence intervals (CI) and assess the prognostic value of deregulated piRNA-823. For survival analysis, the Kaplan–Meier method and COX analysis were used. Results Out of 6104 articles screened, 20 met our inclusion criteria. Our analysis revealed that dysregulated piRNA expression is associated with cancer patient survival outcomes. Specifically, our meta-analysis found that overexpression of piR-823 is significantly linked with poorer overall survival in patients with colorectal cancer and renal cell cancer (HR: 3.82, 95% CI = [1.81, 8.04], I2 = 70%). Conclusion Our findings suggest that various piRNAs may play a role in cancer survival outcomes and that piRNA-823 in particular holds promise as a prognostic biomarker for multiple human cancers. Implications for cancer survivors Our systematic review and meta-analysis of piRNA-823 has important implications for cancer survivors. Our findings suggest that piRNA-823 can be used as a prognostic biomarker for predicting cancer recurrence and survival rates. This information can help clinicians develop personalized treatment plans for cancer survivors, which can improve their quality of life and reduce the risk of recurrence.
first_indexed 2024-04-24T07:15:04Z
format Article
id doaj.art-48b2c5e7ed6449f8b327cfaea7a04174
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-24T07:15:04Z
publishDate 2024-04-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-48b2c5e7ed6449f8b327cfaea7a041742024-04-21T11:21:36ZengBMCBMC Cancer1471-24072024-04-0124111410.1186/s12885-024-12180-2The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)Mohammad Taghizadeh0Tohid Jafari-Koshki1Vahid Jafarlou2Mortaza Raeisi3Leila Alizadeh4Yousef Roosta5Somaieh Matin6Rahele Jabari7Daniel Sur8Abbas Karimi9Department of Molecular Medicine, Faculty of Advanced Medical School, Tabriz University of Medical SciencesDepartment of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical SciencesCancer Institute of Imam Khomeini Hospital, Tehran University of Medical ScienceHematology and Oncology Research Center, Tabriz University of Medical SciencesGastroenterology and Liver Diseases Research Center, Tabriz University of Medical SciencesDepartment of Internal Medicine, School of Medicine, Urmia University of Medical SciencesDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical SciencesDepartment of Nutrition Science, Faculty of Medical Science, Urmia University of Medical ScienceDepartment of Oncology, The Oncology Institute “Prof. Dr. Ion Chiricu¸tă”Department of Molecular Medicine, Faculty of Advanced Medical School, Tabriz University of Medical SciencesAbstract Introduction This article examines the potential of using liquid biopsy with piRNAs to study cancer survival outcomes. While previous studies have explored the relationship between piRNA expression and cancer patient outcomes, a comprehensive investigation is still lacking. To address this gap, we conducted a systematic review and meta-analysis of existing literature. Methods We searched major online databases up to February 2024 to identify articles reporting on the role of piRNA in cancer patient survival outcomes. Our meta-analysis used a random-effects model to pool hazard ratios with 95% confidence intervals (CI) and assess the prognostic value of deregulated piRNA-823. For survival analysis, the Kaplan–Meier method and COX analysis were used. Results Out of 6104 articles screened, 20 met our inclusion criteria. Our analysis revealed that dysregulated piRNA expression is associated with cancer patient survival outcomes. Specifically, our meta-analysis found that overexpression of piR-823 is significantly linked with poorer overall survival in patients with colorectal cancer and renal cell cancer (HR: 3.82, 95% CI = [1.81, 8.04], I2 = 70%). Conclusion Our findings suggest that various piRNAs may play a role in cancer survival outcomes and that piRNA-823 in particular holds promise as a prognostic biomarker for multiple human cancers. Implications for cancer survivors Our systematic review and meta-analysis of piRNA-823 has important implications for cancer survivors. Our findings suggest that piRNA-823 can be used as a prognostic biomarker for predicting cancer recurrence and survival rates. This information can help clinicians develop personalized treatment plans for cancer survivors, which can improve their quality of life and reduce the risk of recurrence.https://doi.org/10.1186/s12885-024-12180-2piRNACancerSurvivalPrognosisSystematic reviewMeta-analysis
spellingShingle Mohammad Taghizadeh
Tohid Jafari-Koshki
Vahid Jafarlou
Mortaza Raeisi
Leila Alizadeh
Yousef Roosta
Somaieh Matin
Rahele Jabari
Daniel Sur
Abbas Karimi
The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)
BMC Cancer
piRNA
Cancer
Survival
Prognosis
Systematic review
Meta-analysis
title The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)
title_full The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)
title_fullStr The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)
title_full_unstemmed The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)
title_short The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis)
title_sort role of pirnas in predicting and prognosing in cancer a focus on pirna 823 a systematic review and meta analysis
topic piRNA
Cancer
Survival
Prognosis
Systematic review
Meta-analysis
url https://doi.org/10.1186/s12885-024-12180-2
work_keys_str_mv AT mohammadtaghizadeh theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT tohidjafarikoshki theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT vahidjafarlou theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT mortazaraeisi theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT leilaalizadeh theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT yousefroosta theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT somaiehmatin theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT rahelejabari theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT danielsur theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT abbaskarimi theroleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT mohammadtaghizadeh roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT tohidjafarikoshki roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT vahidjafarlou roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT mortazaraeisi roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT leilaalizadeh roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT yousefroosta roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT somaiehmatin roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT rahelejabari roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT danielsur roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis
AT abbaskarimi roleofpirnasinpredictingandprognosingincancerafocusonpirna823asystematicreviewandmetaanalysis